King Kennard Holmes – What you need to know about the STIs that most of your patients have

King Kennard Holmes, MD, PhD
Director, Research and Faculty Development, Department of Global Health
Professor of Global Health and Medicine
Adjunct Professor of Microbiology and Epidemiology
Director, Center for AIDS and STD
PI, Center for AIDS Research; and PI, I-TECH
University of Washington

“What you need to know about the STDs that more than half of your patients have”

CAN AIDS BE CURED?

One morning in the winter of 1981, my wife came home after her on-call shift at the U.C.L.A. Medical Center and told me about a baffling new case. Queenie was an eighteen-year-old prostitute, his hair dyed the color of brass. He had arrived at the emergency room with a high fever and a cough, and appeared to have a routine kind of pneumonia, readily treated with antibiotics. But the medical team retrieved a microbe from his lungs called Pneumocystis carinii. The microbe was known for causing a rare fungal pneumonia that had been seen in severely malnourished children and in adults undergoing organ transplants or chemotherapy.

Click here to view full article

Eric Rice – How to Collect Longitudinal Social Network Data in Unbounded Networks of Homeless Youth

CHIPTS Methods Seminar – UCLA-Semel Institute Center for Community Health

How to Collect Longitudinal Social Network Data in Unbounded Networks of Homeless Youth

Eric Rice, Ph.D.

Dr. Rice is an Assistant Professor in the School of Social Work at the University of Southern California.  He has been conducting research in the area of homeless youth since 2003.  He has more than 60 publications, including publications in top journals such as American Journal of Public Health, Journal of Adolescent Health, and Pediatrics. His areas of research include social network theory, social network analysis, and the application of social network methods to behavioral health and prevention research. Dr. Rice is committed to working with communities to help end adolescent homelessness.

World AIDS Day Observations from CHIPTS Director Mary Jane Rotheram-Borus

CHIPTS Director, Dr. Mary Jane Rotheram-Borus, shares her thoughts on World AIDS Day:

It’s World AIDS Day – HIV was first identified 33 years ago and, now, we may be able to eliminate HIV transmission.

In the last five years, Treatment as Prevention, Pre- and Post-exposure Prophylaxis have the potential to revolutionize HIV prevention.

However, to realize this potential, behavioral scientists will need to link closely with biomedical researchers in order to improve adherence, nudge families towards living their healthiest lives, and helping families and communities to address multiple health problems concurrently.

Take time today to reflect on our successes and prepare to meet these last challenges.

W. Scott Comulada – Game of Phones: A Song of Daily Reports With Missing Observations and The Models That Analyze Them


[Download not found]

Game of Phones: A Song of Daily-reports with Missing Observations and the Models that Analyze Them 

 

W. Scott Comulada, Dr.P.H.

Assistant Professor-in-Residence

UCLA Department of Psychiatry & Biobehavioral Sciences

Abstract:
Cell-phone based ecological momentary assessment (CEMA) is an exciting new data collection method. Illicit drug use, sexual behavior, and other HIV-transmission behaviors are reported on a daily basis and in the moment through an electronic device that is already embedded in individuals’ daily routines. The benefits of EMA are realized without the burden of an additional data collection tool. With the capacity to track behaviors at great frequency comes an unwelcome companion of traditional longitudinal studies: missing data. In particular, missing data that is dependent on data not collected by the researcher is problematic, referred to as data not missing at random (NMAR). For example, individuals may not fill out scheduled CEMA on days they are using drugs. Standard statistical models do not adjust for NMAR data and lead to incorrect conclusions. In treatment settings, NMAR patterns overlap with engagement issues and are of interest in their own right. Yet NMAR models have been underutilized due in part to the inability to implement them in standard statistical software packages. Implementation issues have been addressed with the advent of JAGS and other readily available Bayesian software that accommodates NMAR models. A greater awareness of NMAR modeling options in the research community is needed. Towards this goal, I will give an introduction to missing data issues and NMAR models for CEMA data. JAGS code will be provided. Models will be illustrated on CEMA data from pilot studies on youth in outpatient drug treatment and HIV-positive adults. This is joint work with Robert Weiss.

W. Scott Comulada is an assistant professor-in-residence in the UCLA Department of Psychiatry and Biobehavioral Sciences and a member of the CHIPTS methods core. He is part of a cross-disciplinary team of behavioral interventionists, computer scientists, and statisticians that collaborate on mobile phone-based research projects in the behavioral sciences. Dr. Comulada is also a statistician with extensive experience in the analysis of longitudinal and social network data.

Skipp Rizzo – Virtual Reality Goes to War – Advances in the Prevention Assessment and Treatment of Posttraumatic Stress


[Download not found]

War is perhaps one of the most challenging situations that a human being can experience. The physical, emotional, cognitive and psychological demands of a combat environment place enormous stress on even the best-prepared military personnel. Numerous reports indicate that the incidence of post traumatic stress disorder (PTSD) in returning OEF/OIF military personnel is creating a significant healthcare challenge. This situation has served to motivate research on how to better develop and disseminate evidence-based treatments for PTSD and other psycho social conditions. In this regard, Virtual Reality delivered exposure therapy for PTSD is currently being used with initial reports of positive outcomes. This presentation will detail how virtual reality applications are being designed and implemented across various points in the military deployment cycle to prevent, identify and treat combat-related PTSD in OIF/OEF Service Members and Veterans. We will also present recent work being done with artificially intelligent virtual humans that serve in the role as “Virtual Patients” for clinical training of healthcare providers in both military and civilian settings and as online healthcare guides for breaking down barriers to care. The projects in these areas that will presented have been developed at the University of Southern California Institute for Creative Technologies, a U.S. Army University Affiliated Research Center, and will provide a diverse overview of how virtual reality is being used to deliver exposure therapy, assess PTSD and cognitive function, provide stress resilience training prior to deployment and its use in breaking down barriers to care. The talk will conclude with a discussion of how the urgency of war has provided the context and funding for the advancement of these technologies that will soon translate to civilian needs.

Speaker Bio: Albert “Skip” Rizzo is a Clinical and Neuro- Psychologist, and Associate Director of the University of Southern California Institute for Creative Technologies. Skip conducts research on the design, development and evaluation of VR systems targeting the areas of clinical assessment, treatment and rehabilitation. In the psychological domain, he has directed the development/implementation of the Virtual Iraq/Afghanistan VR exposure therapy system for combat-related PTSD and is involved in translating these simulation assets for PTSD assessment and prevention (stress resilience). His cognitive work has addressed the use of VR applications to test and train cognitive functioning. In the motor domain, he develops VR game-based applications to promote rehabilitation in persons with CNS dysfunction (e.g., stroke and TBI). He is also involved in the creation of artificially intelligent virtual human patients for clinical training and for creating online virtual human healthcare guides for breaking down barriers to care in psychological health and TBI.

David Bangsberg, MD, MPH – International Perspectives on Adherence to HIV Treatment & Prevention

CHIPTS was honored to host a Grand Rounds lecture by David Bangsberg, MD, MPH, entitled “International Perspectives on Adherence to HIV Treatment & Prevention”.

Dr. Bangsberg is the Director of the Massachusetts General Hospital Center for Global Health and a Professor at the Harvard School of Medicine, Harvard School of Public Health, and Mbarara University of Science and Technology. He completed medical school at Johns Hopkins Hospital in Balti-more, his internal medicine and chief residency at Columbia Presbyterian Hospital in New York, and Fellowships in Infectious Disease and AIDS Prevention at the University of California, San Francisco. He also holds Master’s Degrees in Public Health from the University of California, Berkeley and the History and Philosophy of Science from Kings College, London. Dr. Bangsberg’s research focuses on social behavioral factors related to HIV treatment access, treatment adherence and treatment outcomes in impoverished populations. Dr. Bangsberg has published over 250 manuscripts and raised over 50 million dollars in funding related to the study of social, behavioral, and structural determinants of HIV treatment in vulnerable populations.


For a copy of his presentation slides, [Download not found]

HIV Housing Conference 2014

On Tuesday, October 21, 2014, the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the National AIDS Housing Coalition co-hosted a one-day conference on “The Housing Determinant: Integrating Housing into the Continuum of HIV Services” at UCLA Covel Commons in Los Angeles. The event was sponsored and supported by the Center for Behavioral and Addiction Medicine (CBAM) in the Department of Family Medicine at UCLA, Los Angeles City AIDS Coordinator’s Office, Los Angeles County Commission on HIV, Friends Research Institute, CHIPTS’ Policy Core, UCLA Pacific AIDS Education and Training Center (PAETC), UCLA Luskin School of Public Affairs, UCLA AIDS Institute, and UCLA Center for AIDS Research (CFAR).

The purpose of this one-day conference was to share the latest research on the impact of housing status on HIV outcomes, to discuss real-world models for integrating housing into HIV prevention and care, to foster collaborations among various stakeholders, and to develop action strategies to inform local policy, community planning, and research directions. The event included speakers such as Mayor John D’Amico of West Hollywood, City of Los Angeles Councilmember Paul Koretz, Mr. Douglas Brooks (Director of the Office of National AIDS Policy), Mr. Greg Millett (Vice President and Director of Public Policy at AmFAR), Ms. Jennifer Ho (Senior Advisor of Housing and Health to HUD Secretary), Dr. Raphael Bostic (Professor and Judith and John Bedrosian Chair in Governance and the Public Enterprise at USC Sol Price School of Public Policy), Dr. Elise Riley (Associate Professor at UCSF), Dr. Joshua Bamberger (Medical Consultant with SF Department of Public Health), Dr. Christopher Gordon of NIMH, and many others. For a complete copy of the event program, please [Download not found]

Below are videos and slides from the event.


Welcome and Opening Remarks


[Download not found]


[Download not found]


Jennifer Ho


[Download not found]


[Download not found]


[Download not found]


Raphael Bostic


[Download not found]


[Download not found]


[Download not found]


[Download not found]


Award

Colloquium: “Dr. Bernard Branson – HIV and HCV: Is Eradication Within Reach?”

November 13, 2014 – Dr. Bernard Branson presented to the Los Angeles County Commission on HIV as part of the CHIPTS HIV Research and Community Colloquia Series.  Dr. Branson has been a persuasive behind-the-scenes architect of public HIV prevention and testing policies in the U.S., Caribbean, and Central America for more than 30 years. He is perhaps best known as the lead author of CDC’s 2006 Recommendations for HIV screening in health care settings and, most recently, the June 2014 HIV testing recommendations that updated the U.S. laboratory testing algorithm for the first time in 25 years. He has extensive experience as a clinician, advocate, community organizer, infectious disease specialist, and clinical virologist. Since leaving his most recent position as Associate Director for Laboratory Diagnostics in CDC’s Division of HIV/AIDS Prevention in October, Bernie has devoted efforts to advancing the adoption of biomedical interventions (such as treatment for HIV viral suppression and pre-exposure prophylaxis) that hold promise for bringing an end to the scourge of HIV. His ambitious visions for prevention and treatment: 0 new transmissions of HIV, and 0 new cases of progression to AIDS among persons living with HIV.

CHIPTS hosts a monthly HIV Research and Community Colloquia Series in collaboration with the Los Angeles County Commission on HIV to highlight current issues and conversations surrounding HIV. Click here for past lectures and check out the events page for more information on future Colloquia presentations!

International baby trial hopes to find Achilles' heel in HIV

The case shocked experts and raised hopes — at least temporarily — that HIV was functionally curable in its tiniest victims.

A Mississippi baby who was infected at birth appeared to remain clear of the virus for nearly two years, even though she was not taking prescribed antiretroviral drugs.

Although medical staff called it a “punch to the gut” when they learned earlier this year that the virus had returned to detectable levels, the young patient’s experience seemed to suggest a possible weakness in the virus.

Specifically, the use of a powerful three-drug cocktail very soon after birth appeared to substantially reduce HIV’s infamous hidden reservoir, and slowed its ability to gain a foothold.

On Monday, the National Institutes of Health announced the start of a global clinical trial in which newborns infected with the virus that causes AIDS will be given medication within two days of birth. (The Mississippi baby received anti-HIV therapy 30 hours after birth. The child’s mother stopped treatment after 18 months.)

Click here to view full article

1 2 3 8